Top compounds associated with response to ZFP3


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.16 1e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.14 5e-06
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA lovastatin CTRPv2 pan-cancer AAC -0.17 9e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
Download CSV